In a mouse model, TGF-β and bleomycin-induced lung fibrosis was blocked by TD139, a galectin-3 small molecule inhibitor with an affinity for carbohydrate-binding domain (26) via inhibiting β-catenin nuclear translocation. The gene discussed is LGALS3; the disease is pulmonary fibrosis.